Revolution Medicines discovers and develops important new medicines for cancer patients by translating frontier oncology targets.

Revolution Medicines has made a major commitment toward discovering and developing small molecule inhibitors of PTPs.

Read more

We have a major commitment to developing bRo5 small molecule drug candidates for frontier targets like 4EBP1/mTORC1.

Read more

Our deep expertise in cancer biology and our drug discovery skills and methods combine to form our product engine directed to frontier cancer targets.

Read more



The company’s 4EBP1 program, additional targets and the product engine broadly represent corporate partnership opportunities.

Contact us